Very insightful interview, management covers their diabetes and CV launches along with the rationale for Oaknet acquisition. Also, they mention that current rules will mostly impact trade generic companies.
https://www.youtube.com/embed/LyjNlQlBEF4
Subscribe To Our Free Newsletter |